2024 New Mexico Statutes
Chapter 27 - Public Assistance
Article 2E - Prescription Drug Pricing
Section 27-2E-1 - Average manufacturer price; filing; reporting.
A. A person who manufactures a prescription drug, including a generic prescription drug, that is sold in New Mexico shall file with the health care authority:
(1) the average manufacturer price for the drug;
(2) the price that each wholesaler or pharmacy benefit manager doing business in this state pays the manufacturer to purchase the drug; and
(3) the price paid to the manufacturer by any entity in an arrangement or contract that sells or provides prescription drugs in New Mexico without the services of a wholesaler.
B. The information required under Subsection A of this section shall be filed annually or more frequently, as determined by the health care authority. The information required under Subsection A of this section is confidential and shall not be disclosed pursuant to Section 27-2E-3 NMSA 1978 and shall not be subject to public inspection pursuant to the provisions of Section 14-2-1 NMSA 1978.
C. A person who engages in the wholesale distribution of prescription drugs in New Mexico shall file with the health care authority information showing the actual price at which the wholesaler or distributor sells a particular drug to a pharmacy.
D. As used in this section, "average manufacturer price" means the average price paid to the manufacturer for the drug in New Mexico, including rebates, discounts and market incentives, after deducting customary prompt-pay discounts.
History: Laws 2003, ch. 381, § 1; 2024, ch. 39, § 92.
ANNOTATIONSThe 2024 amendment, effective July 1, 2024, substituted the health care authority for the human services department as the recipient of prescription drug price information that drug manufacturers must report, and made technical and conforming amendments; and deleted "human services department" and added "health care authority" throughout the section.
